ARYNTA
NDC 24338-109, lisdexamfetamine dimesylate oral, solution, from Azurity Pharmaceuticals, Inc..
- Product NDC
- 24338-109
- Status
- Listed
- Labeler
- Azurity Pharmaceuticals, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219847
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/24338-109 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE10 mg/mL
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24338-109-01 | 24338010901 | 1 BOTTLE in 1 CARTON (24338-109-01) / 90 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/71cdfc97-96af-4378-a44a-6d5d77e7d6b7
Use it
Look up 24338-109 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24338-109 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24338-109. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.